共 130 条
- [1] Jemal A(2009)Cancer statistics, 2009 CA Cancer J Clin 59 225-249
- [2] Siegel R(2008)Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy Pharmacotherapy 28 18S-22S
- [3] Ward E(2002)Targeting the epidermal growth factor receptor for cancer therapy J Clin Oncol 20 1S-13S
- [4] Engstrom PF(2003)An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors Mol Cell 12 541-552
- [5] Mendelsohn J(2005)Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives Ann Oncol 16 189-194
- [6] Burgess AW(2004)Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 337-345
- [7] Cho HS(2005)The epidermal growth factor receptor as a target for colorectal cancer therapy Semin Oncol 32 52-60
- [8] Eigenbrot C(2001)Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on Cancer Stage IV colon adenocarcinoma: implications for a standardized scoring system Cancer 92 1331-1346
- [9] Spano JP(2008)EGFR antagonists in cancer treatment N Engl J Med 358 1160-1174
- [10] Fagard R(2006)Recurrent KRAS codon 146 mutations in human colorectal cancer Cancer Biol Ther 5 928-932